About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Prostate Cancer Drug Abiraterone Can Now Save 6,000 Lives in the UK

by Reshma Anand on March 22, 2016 at 3:27 PM
Font : A-A+

Prostate Cancer Drug Abiraterone Can Now Save 6,000 Lives in the UK

The abiraterone drug which has been discovered by researchers in London is widely used in other parts of the world except for England.

Now, the National Institute for Health and Care Excellence (NICE) has approved the drug for men with advanced prostate cancer who have had hormone therapy but not chemotherapy.

Advertisement


Until now, men with prostate cancer who have had chemotherapy was only offered the drug. But a recent data provided by the drug manufacturer Janssen stating the drug's efficacy and cost-effectiveness has made the NHS agree for its increased accessibility.

The data submitted by Janssen showed that men who took abiraterone after hormone treatment lived for 4.4 months longer than if they were treated with hormone therapy alone. Some men even lived for four years than those who did not take the drug.
Advertisement

Abiraterone taken before chemotherapy can also delay the progression of prostate cancer, increase the survival chances by reducing pain and improve quality of life.

This is the most sought after prostate cancer drug in the world. But, so far, men suffering from prostate cancer in the UK were able to get the drug only through NHS Cancer Drugs Fund.

Through this fund, only 439 people with prostate cancer benefited with the drug. But this new decision will increase access to over 6,000 men currently suffering with advanced prostate cancer in the UK. NICE has recommended abiraterone in combination with prednisone or prednisolone.

Janssen has agreed to reduce the cost of the drug from £2,930 per month to £2,300. Also, it has requested NHS to charge the drug only for the first ten months of treatment for any single patient.

Professor Paul Workman, chief executive of The Institute of Cancer Research in London, said, "This is a big victory for men in England with prostate cancer, and means they will finally catch up with the US, Europe and indeed Scotland in being able to access abiraterone earlier in the course of treatment."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 10 Foods for Decreasing DHT Production and Preventing Hair Fall
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Signature Drug Toxicity Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art Prostate Cancer: Treatment Options 

Most Popular on Medindia

Drug - Food Interactions Find a Doctor Sinopril (2mg) (Lacidipine) Post-Nasal Drip A-Z Drug Brands in India Indian Medical Journals Loram (2 mg) (Lorazepam) Hearing Loss Calculator Blood Donation - Recipients Vent Forte (Theophylline)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Prostate Cancer Drug Abiraterone Can Now Save 6,000 Lives in the UK Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests